Company intelligence / Profile preview

Supera Farma Laboratorios

São Paulo, São Paulo, Brazil

Ownership: Private
Employees: ~707
Development stage: Other

Overview

Supera Farma is a three-way joint venture established in 2011, focusing on marketing, distributing, and selling a portfolio of branded and branded generic pharmaceutical products across multiple therapeutic areas exclusively in the Brazilian retail pharmaceutical sector. The company operates with over 800 sales representatives.

Therapeutic areas: Women's HealthEndocrinologyCardiovascularNeurologyDermatologyPulmonologyGastroenterologyMen's Health
Modalities: Small molecule
Industry: Biotech

Partnerships

Merck (51% ownership through joint venture)Cristália (co-owner, ~24.5% ownership)Eurofarma (co-owner, ~24.5% ownership)

Beyond the preview

Go deeper on Supera Farma Laboratorios.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Supera Farma Laboratorios.

Explore the full profile